Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry

Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database

(2022) Lee S. Nguyen et al.   Nature Communications

Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept

(2022) Lee S Nguyen et al.   Journal for ImmunoTherapy of Cancer

Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis

(2021) Stéphane Ederhy et al.   Frontiers in Oncology

Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis

(2021) Lorenz H. Lehmann et al.   JAMA Cardiology

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

(2021) John R. Power et al.   CIRCULATION

Cardiac troponin T versus cardiac troponin I for mortality risk prediction: Is one biomarker better than the other?

(2020) Giuseppe Lippi et al.   CLINICAL BIOCHEMISTRY

Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

(2020) Yves Allenbach et al.   AUTOIMMUNITY REVIEWS

Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis

(2020) Lili Zhang et al.   CIRCULATION

A decade of immune-checkpoint inhibitors in cancer therapy

(2020) Caroline Robert   Nature Communications

Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance

(2020) Arthur Geraud et al.   Annual Review of Pharmacology and Toxicology

Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque

(2020) Zsofia D. Drobni et al.   CIRCULATION

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

Immune Checkpoint Inhibitor Myocarditis with Normal Cardiac Magnetic Resonance Imaging: Importance of Cardiac Biopsy and Early Diagnosis

(2020) Stephane Ederhy et al.   CANADIAN JOURNAL OF CARDIOLOGY

By Releasing the Brakes With Immunotherapy, Are We Accelerating Atherosclerosis?

(2020) Lavanya Kondapalli et al.   CIRCULATION

Targeting the Immune System in Atherosclerosis

(2019) Tian X. Zhao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

(2019) Douglas B. Johnson et al.   Journal for ImmunoTherapy of Cancer

Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis

(2019) Joe-Elie Salem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms

(2019) Samantha N. Champion et al.   MODERN PATHOLOGY

Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event

(2019) Jennifer Cautela et al.   CANADIAN JOURNAL OF CARDIOLOGY

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

(2018) Daniel Y. Wang et al.   JAMA Oncology

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

(2018) Joe-Elie Salem et al.   LANCET ONCOLOGY

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

(2016) Douglas B. Johnson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation

(2011) De-xiu Bu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis

(2008) Jun Lee et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY